A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
An innovative pathway program led by the UC Davis School of Medicine and Kaiser Permanente to boost the number of Latino health professionals has helped hundreds of undergraduate students pursue careers in medicine.
UC Davis exceeded $1 billion in external research funding in the fiscal year 2022–23. The School of Medicine contributed 40% of this amount, achieving a new research funding record.
Health Media Contacts
Find the best contact for health-related media inquiries.
